# COSCIENS Biopharma Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/COSCIENS Biopharma Inc.). ## Overview COSCIENS Biopharma Inc. is a U.S.-listed life science company focused on natural, plant-based active ingredients. It develops and manufactures specialty cosmetic ingredients, including Avenanthramides and Beta Glucan, for use in skincare formulations worldwide. ## Products & services • Natural, plant-based active ingredients • Avenanthramides for skincare applications • Beta Glucan cosmetic ingredients • Proprietary extraction and manufacturing technologies - **Active ingredients** (100%) — Specialty plant-derived ingredients sold for use in skincare and personal care formulations. - **Avenanthramides** (50%) — Oat-derived active compounds used in cosmetic and skin-soothing applications. - **Beta Glucan** (35%) — Biologically derived ingredient used in moisturizers, barrier-care and skin-health products. - **Extraction and manufacturing know-how** (15%) — Proprietary processes used to isolate, purify and commercialize active ingredients. - Natural, plant-based active ingredients - Avenanthramides for skincare applications - Beta Glucan cosmetic ingredients - Proprietary extraction and manufacturing technologies ## Customers The company sells ingredient inputs rather than finished consumer products, so its customers are primarily skincare and personal-care formulators. Its ingredient portfolio is aimed at brands and manufacturers that want natural, scientifically positioned actives for topical applications. The customer base is therefore concentrated in cosmetic and skincare supply chains rather than retail consumers. - **Skincare brands** (primary) — Buy active ingredients for creams, serums and topical formulations that emphasize efficacy and natural origin. - **Personal-care manufacturers** (primary) — Purchase ingredient inputs for mass-market and premium cosmetic product lines. - **Contract formulators** (secondary) — Source specialty actives to incorporate into third-party skincare formulations. - **Global beauty companies** (secondary) — Use branded or unbranded actives in larger multinational skincare portfolios. - Skincare brands sourcing specialty active ingredients - Personal-care manufacturers formulating cosmetic products - Contract formulators needing natural ingredient inputs - Customers seeking plant-based, science-backed actives - Global skincare brands using Avenanthramides and Beta Glucan ## Geography COSCIENS is headquartered in the United States but operates with a Canadian market presence, including trading and corporate references to Toronto. The business is global in customer reach because its active ingredients are used in skincare brands worldwide. Geography matters because ingredient customers, supply chains and regulatory expectations differ across North American and international cosmetic markets. - Headquartered in the United States - Corporate and market presence in Toronto, Ontario - Ingredients used by skincare brands worldwide - North American base with international customer reach ## Strategy COSCIENS’ strategy is centered on commercializing proprietary natural-ingredient technologies into skincare applications. The company’s competitive position depends on maintaining differentiated extraction know-how, expanding ingredient adoption in global beauty brands, and supporting repeat formulation demand. - **Grow adoption of Avenanthramides and Beta Glucan** (medium-term) — These ingredients are the core revenue drivers and define the company’s market positioning. - **Leverage proprietary manufacturing technology** (medium-term) — Process know-how can support product quality, consistency and differentiation. - **Broaden global skincare customer relationships** (long-term) — A wider customer base reduces dependence on a few formulators or brands. - Commercialize plant-based active ingredients - Differentiate through proprietary extraction technology - Expand use in global skincare formulations - Strengthen relationships with brand and formulation customers ## Risks COSCIENS faces typical specialty-ingredient risks tied to customer concentration, qualification cycles and demand from the personal-care industry. As a plant-based ingredient business, it is also exposed to supply, manufacturing and regulatory risks that can affect consistency, customer adoption and commercialization. - **Customer concentration** [high] — Ingredient businesses often rely on a limited number of brands and formulators for meaningful demand. - **Commercial adoption risk** [high] — Customers must qualify and reformulate around specialty actives before volume scales. - **Manufacturing and extraction risk** [medium] — Proprietary plant-based production depends on stable yields, quality and throughput. - **Regulatory and formulation risk** [medium] — Cosmetic ingredients must meet customer, safety and market-specific requirements. - Customer concentration in skincare supply chains - Adoption risk for specialty ingredients in formulations - Manufacturing yield and process consistency risk - Regulatory and claims risk in cosmetic ingredients ## Accounting Revenue is recognized at a point in time when active ingredient products are sold, so shipment timing and customer acceptance can affect quarterly results. The company also uses judgment in estimates and assumptions, including control assessments for subsidiaries and other IFRS-based judgments that can affect consolidation and reported profit or loss. - **Point-in-time revenue recognition** — Can create quarter-to-quarter revenue volatility - **Deferred revenue** — Affects revenue timing and balance sheet liabilities - **Subsidiary control judgments** — Can materially affect assets, liabilities and income - **IFRS estimation uncertainty** — Can affect reported earnings and balance sheet values - Point-in-time revenue recognition for ingredient sales - Shipment timing can shift quarterly reported revenue - Deferred revenue may arise from customer contracts - Loss-of-control judgments can affect consolidation - IFRS estimates and assumptions influence reported results --- *Last updated: 2026-09-28T11:58:07.682486+00:00*